(Q45874418)
Statements
1 reference
Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors (English)
1 reference
Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER).
1 reference
1 February 2001
1 reference
1 reference
12
1 reference
3
1 reference
315-320
1 reference